Historically, diagnosis has been achieved with multiple blood tests. However, this process can be time-consuming, expensive and in some cases does not provide accurate results.
In an attempt to address these diagnostic challenges, the researchers, with funding from Dechra, assessed anonymised data from 939 dogs which had been tested for Cushing’s syndrome from the VetCompass population of 905,554 dogs and 886 veterinary practices across the UK1.
Using structured clinical data to look at the dogs’ demographics, clinical signs at presentation and laboratory results, machine-learning algorithms were applied to predict a future diagnosis of Cushing’s syndrome. Dogs suspected of having Cushing’s syndrome were included in the analysis and classified based on their final reported diagnosis within their clinical records.
The researchers say that the findings indicate that machine-learning aided diagnosis could predict the diagnosis of a practising veterinary surgeon and that using machine-learning methods in clinical practice could contribute to improved diagnosis of Cushing’s syndrome in dogs.
Additionally, further development of these algorithms could lead to earlier, more reliable and cost-effective diagnoses and therefore, better clinical care for dogs with Cushing’s syndrome. This could also create opportunities for this technology to be applied to other clinical problems.
Imogen Schofield, lead author and PhD student at the RVC, said: “Machine-learning algorithms, like those used in this study, are already widely integrated in our day-to-day lives to help make certain decisions, such as Google or Netflix recommendations. Now this technology can be harnessed to help improve diagnostics in veterinary practice.
"By embracing the use of machine-learning methods, we are a step closer to providing vets in primary-care practice with an easy to use, low cost and accurate test that can support the often frustrating process of diagnosing Cushing’s syndrome in dogs."
Greg Williams, Senior Business Manager at Dechra Ltd. and Industrial Supervisor of the PhD studentship, said: “By funding Imogen's PhD and working with the RVC we have been able to develop validated clinical scoring and quality-of-life assessments to help vets deliver effective control and management of Cushing's syndrome in dogs.
Reference
Elanco Animal Health has announced the launch of Kexxtone this month, a new treatment which it claims can reduce the incidence of ketosis in dairy cows by 74%* following a single treatment.1
Kexxtone is a targeted solution for any dairy cow or heifer that is expected to develop ketosis around the period of calving. It is administered as a bolus,and provides coverage during the main risk period for the condition.
Ketosis often goes undetected because the signs are not immediately apparent. However, it is a common condition, affecting around 30% of cows2 and has a negative impact upon cow health, fertility and milk production. Ketosis can result, on average, in milk losses of around 350-500 litres per cow4 per lactation. The cost of production losses and disease related consequential losses due to subclinical ketosis has been estimated at around 250-600 EUR per cow.5
Elanco says this new approach is likely to significantly expand the array of options open to vets actively involved in dairy herd health management. Kexxtone comes with the benefit of a zero day milk and meat withdrawal3 and the formulation is based on monensin - a molecule with a long history of beneficial use.
According to the company, Kexxtone uses novel technology to allow a continuous and regular release of the active ingredient into the rumen which forms a gel when exposed to rumen fluid. This gel is progressively released into the rumen by a pressure sensitive spring in the Kexxtone device. The active ingredient shifts the microbial balance in the rumen to produce more of the glucose precursor propionic acid, therefore increasing glucose delivery and ultimately increasing the energy available to the cow. This improvement in energy utilisation buffers dairy cows against the tendency to drop into negative energy balance during the transition period around calving and early lactation - the major cause of ketosis.
Mike Steele, Technical Consultant at Elanco said: "Kexxtone offers an exciting opportunity in which everyone wins - vets who can offer positive interventions able to make a big impact on the bottom line, are going to be increasingly integral to their farm clients' herd health planning framework. It's no longer just about nutritional intervention and emergency salvage; it's about being able to proactively easily measure the true herd prevalence of ketosis and where appropriate, take preventative targeted action to really make a difference."
Kexxtone is available to order now from veterinary wholesalers - for further information contact the Elanco Territory Manager or call Elanco Animal Health on 01256 353131.
References
Hertfordshire-based, multi-specialist veterinary referral centre Davies Veterinary Specialists' new pro bono scheme has saved the life of a young German shepherd dog twice in fortnight.
'Apollo' first impaled himself on some broken fence panels whilst playing. A splinter of wood, which was around 5cm long and 1.5cm wide, became lodged between his heart and lungs. However, because he initially had no symptoms and there was no obvious puncture wound, his owner Sam Russell from Leighton Buzzard wasn't aware that anything was wrong. It was a week later when the dog suddenly became very anxious, uncomfortable and was struggling to breathe, that Sam rushed him to her local vet practice, Heath and Reach in Bedfordshire.
Hannah Johnston's initial diagnosis was that the dog had some foreign material lodged internally that was causing an infection. Without an urgent CT scan and surgery his chances of survival were minimal, but his owner was uninsured and had no means of affording the treatment. Hannah had recently read about a pro bono scheme introduced by Davies Veterinary Specialists and believed that Apollo's case fitted the criteria.
She said: "It was heart wrenching to think that a young dog, with such a caring owner, was very likely to lose his life and I was determined to do anything I could to help. I couldn't help shedding a tear when DVS agreed to treat him, as I knew Apollo now had a chance. His owner had recently had an awful spate of bad luck and was so deserving of DVS's help."
Manuel Jiménez Peláez, European Veterinary Specialist in Surgery at DVS, who operated on Apollo, said: "A CT scan showed a large, fluid-filled cavity, a partially collapsed lung and a sharp, thin, elongated structure, lodged between Apollo's lungs and his heart. We drained the cavity and successfully removed the foreign body. We also had to remove most of the irreparably damaged left lung."
Apollo was in hospital for two weeks, five days of which were spent in intensive care in a critical condition. Sam was thrilled when she was eventually able to take him home, but two days later disaster struck again. Apollo was diagnosed with gastric dilation volvulus. He needed surgery within six hours to survive the condition and DVS once again stepped in to operate as an emergency, free of charge.
Apollo has made a full recovery is now back at home with the Russell family. Sam Russell said: "Apollo has always been so determined and full of life. Even when he was dangerously ill and in intensive care he wouldn't give up and tried to rouse himself to come home with me. For Davies Vet Specialists to save my dog once is nothing short of amazing but for them to save him twice makes me speechless with gratitude. To be shown such kindness after a dreadful run of bad luck would leave anyone stuck for words."
All first opinion practices are eligible to apply for the DVS pro bono scheme, which will allow an average of one patient per month to receive free treatment. Requests will be based on advocacy from the clinical head of the referring practice and on genuine need. To find out more visit http://www.vetspecialists.co.uk/ or call Dr Clive Elwood, Managing Director, on 01582 883950.
To carry out the practice of veterinary medicine, a veterinary practitioner must be registered in the jurisdiction in which they are practising ie a veterinary practitioner who practises veterinary medicine in the Republic of Ireland must be registered with the VCI; likewise, a veterinary surgeon who practises in Northern Ireland, England, Scotland or Wales, must be registered with the RCVS.
EU Directive 2005/36EC enables a veterinary surgeon who is lawfully established and registered in an EU member state to provide services on a temporary and occasional basis in another member state. This service allows registered veterinary surgeons to occasionally practise in other countries in the European Union for short periods, up to a maximum of 30 days per year.
From 1st January 2021, the Directive will no longer apply to veterinary practitioners from the Republic of Ireland who may want to provide veterinary services in the UK and that they would therefore need to be registered with the RCVS even if provision of these services is temporary and occasional.
However, in October 2019 the Presidents of the RCVS and the VCI signed a Mutual Qualification Recognition Agreement. The agreement means that the degree in veterinary medicine from University College Dublin can be recognised by the RCVS, and the current eight RCVS-recognised UK veterinary medicine degrees can be recognised by the VCI. The recognised qualifications are accepted as the basis for registration to practise veterinary surgery by the RCVS in the United Kingdom and veterinary medicine by the VCI in the Republic of Ireland.
The VCI and the RCVS emphasised that regardless of whether a trade agreement has been signed between the EU and the UK by 1 January 2021, this will have no bearing on the Mutual Qualification Recognition Agreement currently in place.
Niamh Muldoon, CEO and Registrar of the Veterinary Council of Ireland, said: “This historic agreement will enable graduates of Irish and UK veterinary schools to continue to seek to practise in the other country when they wish. We look forward to continuing to collaborate with our colleagues in the RCVS in the future for the benefit of the profession in both countries.”
Mandisa Greene, President of the Royal College of Veterinary Surgeons said: “I am very glad to be able to affirm our continuing working partnership with our friends and colleagues in the Republic of Ireland. We know that veterinary surgeons based both in Northern Ireland and the Republic of Ireland have clients and undertake work on both sides of the border, and this Mutual Recognition Agreement will help to ensure that UK and Ireland-qualified veterinary surgeons are able to register in each other’s jurisdictions where required. I too look forward to continuing to work closely with the VCI both on a bilateral basis, and via pan-European institutions such as the Federation of Veterinarians of Europe.”
The company points to research which showed that 42% of cats and 28% of dogs have lesions which are only detectable on x-ray1.
Failing to identify teeth with root lesions can have a significant impact on patient welfare, causing ongoing pain and eventual tooth loss.
The first priority for the CVS clinical improvement project was to review how effective its first opinion small animal practices were at using radiography in dental examinations.
In July 2021, only 16.2% of dental cases had radiography performed and clinicians were mostly using visual examination to guide decision making.
The project then identified the barriers to using dental radiography as: a lack of dental radiography equipment in a practice, a lack of clinician confidence in taking and interpreting the radiographs and a belief that pet owners would not want to pay for it.
To address the first issue, CVS installed new dental radiography machines at over 104 sites, at a cost of £615,000 over the course of the year.
The company then upskilled its vets and nurses in dental radiography - looking specifically at getting good quality radiographs and interpretation.
Finally, the company conducted an audit of each participating practice’s dental radiology data, updating it each month and sharing the results with the practices..
One year on, CVS says the data shows that 43% of dental cases in project practices are now using dental radiography as part of their consultation.
In the best cases, some practices have been using radiography in 100% of cases.
Hub Clinical Lead Deborah Komianos said: “When you open a patient’s mouth and look inside, seemingly normal teeth are oftentimes not normal.
"So vets and nurses can risk missing periodontal disease.
“Dental radiology has historically been underutilised but we believe it adds valuable information to dental consultations and is an important decision-making tool.
“We’re thrilled with the early results in our practices.
"It shows there’s been a real change of mind-set and behaviour towards using X-rays in dentistry – as well as increased confidence in execution."
The programme, which was developed in collaboration with the NHS Leadership Academy, is designed to teach a number of skills that underpin good leadership, including decision-making, resilience, implementing an inclusive culture and encouraging reflective learning approaches. It comprises two free-to-access courses and an optional paid for assessment.
The College says that one of the programme's most popular aspects is its audio drama, which follows the lives of veterinary professionals living in the fictional county of Glenvern. The stories that depict the characters’ working lives seek to reveal the diverse leadership challenges that veterinary professionals face on a day-to-day basis. This in turn prompts the listener to reflect, consider how they would respond, and learn from their own experiences as well as those of other people.
The first course was piloted this summer, with over 550 veterinary surgeons, veterinary nurses, students and practice managers helping the College to develop and refine the material, whilst a group of learners are currently piloting the second course in the series.
Simon Patchett MRCVS, who works at Vets Now 24/7 Emergency and Specialty Hospital, Glasgow, said: "This course really highlighted leadership qualities that are often taken for granted. The course demonstrates that you do not need a status position in order to demonstrate effective leadership even though status positions are often where we look for leadership. I would recommend this course to both vets and nurses in clinical practice - it's a real eye opener, and as a result of doing the course perhaps we can see less age-restricted approach to leadership within the veterinary profession?"
Given the overwhelmingly positive feedback received on the first course the RCVS has now opened the programme to all veterinary professionals.
The programme is now accepting registrations for a new cohort of learners to begin the first of three courses on 26th November. A ‘sign-up’ email will be sent out to all veterinary surgeons and veterinary nurses ahead of the course starting.
Director of Leadership and Innovation at the RCVS, Anthony Roberts, said: "I am very pleased to be able to announce the launch of this programme. I would urge anyone with an interest in developing their leadership skills, as well as those looking to refine their longstanding leadership skills, to take part. The feedback we have received on the first course in this programme [please see Notes to Editors] has shown us that this MOOC has a far-reaching application, and is both educational and enjoyable. Whether you are a vet, veterinary nurse, practice manager or student, this programme will be relevant and useful in your professional career."
For more information, visit: www.rcvs.org.uk/leadershipmooc or email: leadership@rcvs.org.uk
AniDent is a dental care range for cats and dogs - a rinse, a toothpaste and a gel - created with Virbac to help prevent periodontal disease.
Anident joins VetSoothe, a range of dermatology products which includes shampoos, ear cleaners and skin wipes, developed with Vetruus.
Earlier in the year, IVC also launched Joints & Mobility with Omega-3s, an addition to it's VetPro range, developed with one of the company's orthopaedic experts, Jamie McClement.
On the equine side, the company has also launched EquiXcellence, a range of equine nutritional health and wellbeing supplements.
VetSurgeon asked what longer term plans the company has for its exclusive brand product range.
An IVC Evidensia spokesperson said: "We're developing own brand veterinary products specifically where we think we can see areas we can add value for our practices, pet owners, and patients. In the case of Anident, we saw there was an opportunity to make oral care easier by offering a range of options to suit pet owners' needs.
"In the case of Joints & Mobility with Omega-3s, there is research which has shown that high levels of Omega-3s EPA & DHA can greatly support freedom of movement and pain, which was the key focus when developing the product.
"We plan to continually enhance our own brand portfolio across our UK and Europe practices with some exciting product launches on the horizon."
Photo: Gerhard Putter BVSc MRCVS MANZCVS (Veterinary Dentistry and Oral Surgery) Diplomate of the European Veterinary Dental College uses Anident on a big cat
Dechra Veterinary Products has launched Cyclo Spray, an antibiotic spray for veterinary professionals treating hard to reach sites when handling cattle, sheep and pigs.
Dechra says the new product has been developed for use at any angle, even upside down.
Cyclo Spray (chlortetracycline hydrochloride 2.45%) is indicated for the treatment of superficial claw and hoof infections and the prevention of infections of superficial traumatic or surgical wounds.
Dechra Veterinary Products Brand Manager Emma Jennings said: "Vets dealing with livestock can often find that they are twisting themselves into awkward positions to get to hard to reach sites with traditional spray can treatments. Not only are they having to find the right angle to ensure the can works, but also potentially the treatment can drip or take time to dry.
"We've introduced Cyclo Spray to our portfolio to help combat some of those difficulties - it is a new 360 degree spray can allowing users to mark the site of application with confidence from whatever angle. It is non-drip, fast-drying with excellent adhesive characteristics and contains a non-toxic colouring agent."
Cyclo Spray is available in 211ml and 422ml can sizes. No withdrawal days are required for meat and milk.
To promote the launch of the new product, Dechra has also launched a competition giving entrants the chance to win a two day trip to London for two people to ride the London Eye and experience the capital from a 360 degree vantage point.
To enter the competition, with the prize including return rail travel, and dinner, bed and breakfast in a 4* hotel, visit www.dechra.co.uk to download an entry form.
Membra is a transparent, water-resistant, non-toxic, biodegradable bandage replacement consisting of a hydrogel polymer which can be applied to open wounds.
It is initially applied as a liquid and quickly gels into a thin, flexible layer over the site.
The initial liquid phase of Membra allows it to cover open and irregular spaces as well as suture lines and it dries in minutes to form a barrier that covers and protects the incision site or wound.
Being transparent, Membra allows the wound to be seen by the veterinary team and pet owners.
Membra lasts for up to 14 days and naturally biodegrades over time.
Animus says that Membra lowers the risk of infection or dehiscence.
The company also says that hydrogel polymer has been shown to replace the need for adhesive bandaging on suture lines following major TPLO surgery.
A study concluded that the polymer did not appear to raise the prevalence of incisional complications after TPLO surgery and lasts for 14 days, rather than 24-48 hours with traditional bandaging1.
Nick Butcher MRCVS, owner of Animus Surgical in the UK, said: “Regular bandaging of open wounds can be costly, time-consuming and stressful for owners and their pets, requiring frequent visits to the practice.
"The bandaging of some open wounds can be impossible because of the location of the lesion or the affected species (e.g. exotic or aquatic animals) and more aggressive or nervous patients may require sedation.
"Used bandages also add to the volume of clinical waste generated by the practice which requires incineration
“We are therefore delighted to launch Membra to veterinary teams in the UK.
"It has been very successful in the U.S. and we already have a number of UK vets using the product as Membra can positively affect the outcome of open wound management across a range of species, without the need for regular bandage changes.”
To find out how to apply Membra, a range of YouTube videos are available showing a selection of case examples: https://youtube.com/@sutureseal5917.
www.animussurgical.com.
Ceva Animal Health has extended its Meloxidyl dogs and cats’ range with the launch of a new 5ml Meloxidyl oral suspension for cats.
The company says the new bottle size will provide more prescription options for veterinary practices currently stocking 15ml bottles and is a perfect post-surgery size to send patients home with. The bottles are also clear brown in colour; designed to make it easier for cat owners to see how much liquid is left in each bottle.
Meloxidyl oral suspension for cats contains meloxicam for the alleviation of pain and inflammation. It is licensed for the treatment of musculo-skeletal disorders and the alleviation of post-operative pain.
Rob McLintock, business unit manager at Ceva Animal Health said: "The new 5ml Meloxidyl oral suspension for cats’ bottle will provide veterinary practices with more prescription options for the management and alleviation of pain and inflammation in cats."
To support the launch of the new 5ml Meloxidyl presentation, Ceva is running a competition to win one of five BSAVA Manuals of Anaesthesia and Analgesia by answering one question: ‘How many millilitres are in the new Meloxidyl cat bottle’?
To enter the competition, email analgesics-group@ceva.com. Include ‘Meloxidyl competition’ in the subject line and contact details and the answer to the question in the main body of the email.
For further information on Ceva’s analgesic product range, contact your local Ceva territory manager, email analgesics-group@ceva.com or call 01494 781510.
The research found that 93% of practices have a washing machine on site, but two thirds of those use a domestic machine rather than a commercial one. 69% of staff also take their uniform home to wash in a domestic machine.
Only commercial machines conform to the WRAS regulations, with thermal disinfection capabilities to minimise the risk of cross infection.
The survey also provided an argument for using a robust commercial machine able to cope with high levels of usage and the variety of materials needing to be cleaned: 83% of practices said they use their machines more than once a day and listed bedding, drapes and gowns as the most common materials that need to be cleaned regularly.
Les Marshall, Sales & Marketing Director at Miele Professional, said: "Our research shows that veterinary staff realise the importance of hygiene when cleaning their laundry. At Miele Professional we understand that preventing infection is key. When caring for animals who need medical care, reliable and effective equipment that can wash items ranging from bedding to gowns to reusable bandages is essential.
"As a leading supplier to the care and hospital sectors, all our machines are tested and approved to Water Regulatory Advisory Scheme (WRAS) category 5 for mains connection in any high-risk establishment."
The company says that in addition to meeting WRAS category 5 requirements, it's machines:
Miele Professional is exhibiting at the London Vet Show and will be holding a seminar on 'Controlling the risk of infection with a commercial laundry system' in the Business Theatre on 18 November, 12-12.50pm.
The seminar will explore the benefits of using a commercial laundry over a domestic machine, best practice around thermal disinfection and why it’s vital for veterinary practices to meet WRAS category 5 requirements.
For more information visit www.miele.co.uk.
95 respondents were surveyed online in June 2016
NOAH's third Brexit Barometer found that where in the last report, 17% of its members reported feeling 'very' or 'somewhat pessimistic', that figure has now risen to 32%.
Meanwhile, the National Audit Office has revealed in its 'Progress in Implementing EU Exit' report that Defra has been prevented from consulting with the veterinary market by DExEU.
The report states that Defra is one of the government departments most affected by EU Exit and looks in detail at four of Defra’s main workstreams, including ‘import of animals and animal products’ and ‘exports of animals and animal products’.
In an accompanying press release, the National Audit Office notes that in a no-deal scenario there will be a significant increase in certificates needing to be processed by veterinary surgeons. It says: "Without enough vets, consignments of food could be delayed at the border or prevented from leaving the UK. Defra intended to start engaging with the veterinary industry in April 2018, but has not been permitted to do so and now plans to launch an emergency recruitment campaign in October to at least meet minimum levels of vets required. It plans to meet any remaining gaps through the use of non-veterinarians to check records and processes that do not require veterinary judgement."
The BVA says it has previously outlined concerns about the potential for diluting veterinary certification, and is calling on the Government to fully engage with the veterinary profession before making any changes that could impact the UK’s ability to trade animal products safely and in line with high animal welfare standards.
The RCVS has also weighed in. Amanda Boag, RCVS President, said: "We are glad to see the National Audit Office report recognises that a ‘no deal’ Brexit scenario would be likely to reduce the supply of EU veterinary surgeons to the UK and cause uncertainty regarding the status of those EU veterinary surgeons who are currently living and working in the UK and that this would have a particularly serious impact on necessary veterinary work in public health and certification.
"We continue to engage with Defra and, like the BVA, we want to emphasise the essential need for Government to consult with the profession to ensure their plans meet requirements, including maintenance of the high veterinary standards for which the UK is known. We also want to highlight the importance and value of the veterinary profession in other areas of society including caring for pets, horses and farm animals as well as research, education and industry, and emphasise the impact of workforce shortages on all sectors."
BVA President Malcolm Morley said: “Judging this competition has been genuinely both extremely enjoyable and really difficult.
"The entries this year have absolutely surpassed expectations and the level of talent on display is amazing.
"However, the photographs we have chosen are all well worthy of being finalists.
"From photos that made us laugh out loud, to others that made some of us feel close to tears, they evoked a range of emotions, but we were also impressed by the quality of the images, the creativity of the photographers and the composition of the photos, as well as the stories behind the lens.
The finalists are:
Vets at work
All creatures great and small
Happy pets that make us smile
The winners will be announced at BVA Live at Birmingham’s NEC in May, where this year there is also an opportunity for BVA Live delegates to vote for their favourite image from the shortlist, with a new ‘People’s Choice’ winner being announced in the weeks following the event.
The new range allows for gradually increasing support for the CKD patient according to the International Renal Interest Society (IRIS) stage, reducing phosphorous levels whilst avoiding early protein reduction and the associated lean mass loss correlated to a reduction in life expectancy.
Virbac says Veterinary HPM Kidney & Joint contains high quality protein, of which more than 85% is of animal origin, to support body condition and limit renal workload.
All of the products in the range contain Mobility Plus Complex, a mix of chondroprotective agents for joint support which are designed to increase joint flexibility and mobility with high levels of Omega 3 and DHA.
Dan Johnson, Product Manager at Virbac said: "CKD is the first cause of mortality at, or after, 5 years of age and osteoarthritis is highly prevalent but under-diagnosed in senior cats, with most cats being diagnosed at an advanced stage.
"So with Veterinary HPM Kidney & Joint, Virbac hopes to provide clinicians with a significant advancement in the nutritional management of these feline pathologies."
Veterinary HPM Kidney & Joint is presented in three dry and two wet formats:
Vétoquinol has launched a competition to promote its NSAID Cimalgex, in which a veterinary surgeon or nurse will win (get this) an Aston Martin DB9.
In addition, Vétoquinol will be offering the winner a day's performance driving course at the Millbrook Proving Ground and £1,000 towards the costs of insurance.
To enter you need to answer some questions relating to Cimalgex. Until the end of BSAVA Congress, you can do this at the Cimalgex stand (821). Thereafter, you can enter the competition by visiting: www.CiMyDog.co.uk and answering the same questions online.
This competition will close and the winner will be announced on the last day of London Vet Show 2014.
Robert Simpson, Cimalgex Product Manager said: "Giving this beautiful DB9 to a vet or nurse in the UK is an incredibly exciting opportunity. This competition stands out as one of the most sensational and audacious I have heard of in the veterinary industry and hopefully it will create a lot of fun and excitement both at BSAVA and beyond."
VetSurgeon.org has announced the launch of VetSurgeon Jobs, a new service designed to change the way veterinary surgeons are hired, saving veterinary practices hundreds, sometimes thousands of pounds.
Since 1761, when the veterinary profession first came into existence, employers have had no choice but to advertise job opportunities for veterinary surgeons and practice managers in magazines.
Editing, printing and publishing a magazine is an eye-wateringly expensive business, costs which have been reflected in the price advertisers have had to pay.
The Internet has brought those costs right down. Furthermore, in a survey of job seekers carried out last earlier this month by VetSurgeon.org, 70% said they spend most time browsing jobs online these days, as opposed to in a magazine.
However, when you look at the costs of advertising on websites published by veterinary magazine publishers, which start at £395 and quickly rise to £795 for a 28-day online advert, it is clear that these prices still reflect the considerable costs of magazine production.
Today, VetSurgeon.org launches it’s online-only job advertising service, priced simply at £99+VAT, which gets you a 60-day advert on the website most followed by UK veterinary surgeons.
That price doesn’t just offer a considerable saving over alternatives in the veterinary profession, it also beats the major online-only players outside the profession (including Monster, Reed and Totaljobs)
There’s more to it than just price, though. Unlike the alternatives, VetSurgeon Jobs is not an 'off-the-shelf' solution, but something designed from the ground up for the veterinary profession.
For jobseekers, VetSurgeon Jobs has been designed to make finding the right job as simple and straightforward as possible. Just enter the postcode and search radius, and the available jobs re-order by distance. You can subscribe to be alerted of only those jobs that meet your very specific criteria (such as locum positions within a given radius). Perhaps most importantly, VetSurgeon Jobs is an integral part of the thriving community on VetSurgeon.org. So you can add your CV to your online profile and then engage directly with employers on the site.
For employers, VetSurgeon offers the opportunity to publish a more engaging, interesting advertisement than is currently offered anywhere else, including maps, photos, logos and headline propositions.
Arlo Guthrie said: "It’s a cliche, but if ever there was a 'win-win' situation, this is it. I’m able to offer you the chance to save a small fortune, whilst making some for myself and to reinvest in yet more features designed to support your profession."
For more information, visit https://www.vetsurgeon.org/jobs/, ring 0207 183 2511 or email support@vetsurgeon.org.
And if you want to support our efforts ... please share this story using the links immediately below.
The website now contains a range of information on Alfaxan including user experiences, sections on best practice anaesthesia, webinars and details of Jurox’s anaesthesia roadshows.
The webinars include a presentation which explains how to use Alfaxan to achieve the best anaesthetic experience for the patient. There is also series of short online webinars on rabbit anaesthesia:
An online CPD certificate will be issued to veterinary professionals who have viewed each webinar, after they have taken a short online questionnaire.
The Alfaxan website also offers downloadable resources such as the new Considerations for Anaesthetising Rabbits expert panel guidelines booklet, AVA Anaesthetic Safety Checklist Implemenation manual, AVA Anaesthetic Safety Checklist and Alfaxan resource guides, user guides, dose charts and monitoring charts.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "Our new Alfaxan website is an educational hub that enables veterinary professionals to learn more about best practice anaesthesia and how this can be implemented in their own clinics. With Alfaxan’s new pet rabbit indication we have included an emphasis on rabbit anaesthesia and how this differs from anaesthesia in cats and dogs."
For further information, visit www.alfaxan.co.uk, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
Earlier this year, the RCVS Council approved the roll-out of a more outcomes-based model of CPD to encourage veterinary professionals to engage in greater reflection on learning and development, and the impact that it has on their professional practice.
To support this approach, Council also approved the development of a new CPD recording platform designed to be more intuitive and to make it easy to record CPD in real time.
The College says the new platform – which has the working title of 'One CPD' – will be a ‘one stop shop’ CPD management solution for veterinary surgeons and nurses at all stages of their careers, including veterinary students and student veterinary nurses.
Richard Burley, RCVS Chief Technology Officer, said: "We’re excited to open up access to this powerful, next-generation, tool we’ve been building and welcome our members into an important phase of the development process. Testing with our members will be absolutely critical in delivering the very best experience possible for all those that use 'One CPD' in the future. Ease of use and truly valuable functionality are key deliverables for us and both these need the feedback of our members to perfect."
Dr Linda Prescott-Clements, RCVS Director of Education (pictured right), added: "The first stage of the development of the CPD recording platform is due to finish in October and so we are looking for a cohort of both veterinary surgeons and nurses who can spend a few months this autumn using the new platform to record and reflect on their CPD, in order to test out some of the new features which aim to make this process so much easier to do. We will consider their feedback carefully in order to improve the recording platform ready for launch in January 2020.
"The new ‘One CPD’ platform will ultimately replace the current Professional Development Record, and its use will become mandatory for recording CPD from January 2022.
"In addition to setting up the testing group, we are also looking to meet with key CPD providers for veterinary surgeons and veterinary nurses over the coming months to discuss our plans for outcomes-based CPD and the development of the recording platform in greater detail."
Veterinary surgeons who'd like to take part in the testing for the CPD app, as well as CPD providers who want to discuss the College’s CPD policy plans, should contact Jenny Soreskog-Turp, RCVS CPD Officer, on cpd@rcvs.org.uk or 020 7202 0701.
Merial has launched Supleneo flex, a nutraceutical supplement designed to be part of a Total Joint Health programme for dogs, administered once daily.
Merial says the new product supports its market position as a leading force in canine pain management, supported by the canine NSAID Previcox.
According to the company, Supleneo flex is suitable for all breeds, sizes and ages, and contains three key ingredients associated with joint health: glucosamine hydrochloride, chondroitin sulphate and mixed tocopherols (Vitamin E). It is designed to be used as part of an all-round joint care programme, alongside nutrition, weight management and exercise.
Merial says the soft chews are highly palatable and when tested against a range of competitor products, a significant difference was observed, with Supleneo flex readily taken and preferred by dogs.1
Supleneo flex is supported by printed and digital materials to help with owner education, including a waiting room video and an online information website at www.supleneoflex.co.uk for clients.
For veterinary surgeons, Merial is offering product advertising support and a loyalty programme.
For more information, telephone Merial on 0870 6000 123 or contact your Territory Manager.
The programme for the day includes a talk by Matt Rendle, an exotics veterinary nurse, about wound healing in reptiles and the work of the Veterinary Wound Library.
There are also talks about current veterinary practice concerning Chelonia (with a focus on egg retention), the Asian turtle crisis, zoo conservation work, reptile rescue work and perceptions of Chelonia in captivity.
Tickets cost £30-£50, and include refreshments, lunch and optional Sunday workshops.
For more details or to reserve your place, email: turtlesurvivaleurope@gmail.com, or visit: https://www.turtlesurvival.eu/
In 2014 ioLight co-founders, Oxford physicists Andrew Monk and Richard Williams, filed a patent application for a pocket-sized digital microscope with a performance that compares with expensive laboratory microscopes. They asked Cambridge Industrial Design to realise the product, briefing them that the device would need to deliver images with one micron resolution (required to view human or animal cells) onto a smartphone or tablet, be pocket-sized, easy to use, and economical to build in medium to high volumes.
One of the biggest challenges was in making the unit pocket-sized, which meant it had to be foldable, something which could have led to a loss in the rigidity needed to achieve high resolution images. This challenge was overcome with the use of a single hinge which the company says makes the ioLight both portable and robust.
Alex Jones, Managing director of Cambridge Industrial Design said: "We recognised immediately this was a great idea but the design brief was certainly a challenge. Fortunately, challenges can sometimes bring out the best in designers. The final design is a real success both aesthetically and ergonomically, and this award is a fantastic acknowledgement for the design process and the final product that we have created together with ioLight."
ioLight is also celebrating another success: closing its second round of equity funding after raising £320k from 335 investors on the Crowdcube platform (128% of the initial target).
The company says the new funding will allow it to promote the microscope to a wide range of target markets including veterinary surgeons, education, laboratory and field research, museums and public engagement as well as to international markets.
Andrew Monk, ioLight’s co-founder said: "The product is so simple to use that it is the ideal communication tool for explaining science to the public, students and customers. The microscope lets everyone see the same image so the discussion is about the picture not the tools. It’s a perfect fit for government public engagement campaigns, which are well funded at the moment. We are absolutely delighted that this funding provides us with the opportunity for both product development and to reach out and make microscopy available to so many more people."
iRecall Consent Management falls into two parts: an initial three staged campaign to gain clients' consent before the 25th May deadline, then ongoing maintenance of the database, managing existing clients' communication preferences and gaining consent for new clients.
Thereafter, iRecall will cross reference consent and communication preferences for any iRecall-powered outbound marketing communication for a practice.
Practice-branded client consent requests are created in real time using live practice data and are personalised for each individual client and their pets.
Consent Management uses the company's SMARTdelivery technology to maximise response rates: first selecting the best delivery method (SMS, email or letter) for each client, based on current information in the practice management system. If a message fails to send because of an invalid number or email address, Consent Management automatically selects the next delivery method.
iRecall says Consent Management already interfaces with the six leading practice management systems, and can interface with any system on request.
Jamie Crittall, Director of Virtual Recall and himself a practice owner said: "Practices need to stop thinking that GDPR is a burden but see it as opportunity to forge stronger relationships with their clients and helping them to keep their pets healthy. Practices who treat their clients’ personal data with the same care that they show their pets will be rewarded with greater trust and loyalty, ensuring the future success of their business. Furthermore, it’s the perfect opportunity for practices to re-engage with previously lapsed clients to make them active and loyal once more - a massive value add."
For more information, visit: http://www.virtualrecall.com/
In his talk, 'Digital Veterinary Practice', Adam presents an exciting and compelling vision as to how technology will transform the profession and enable veterinary surgeons to offer better care to more patients.
His talk begins with an interesting look at how technological change has gathered pace in recent years, before considering some of the emerging technologies that could be applied to veterinary practice.
In particular, he talked about the so-called 'Internet of things': the way more and more 'things' other than computers are connected to the Internet.
There are now about 9bn 'things' connected to the internet, by 2020 there are expected to be 50bn. Adam predicted that more and more of them are going to be worn by animals: to measure reproductive health in farm animals; to track performance in equines; and to monitor behaviour and activity in companion animals.
Adam discussed how there is already a smart litter box which measures an animal’s habits, an oral pill camera that can take 360 degree internal photos, 3D printed drugs and digitised microscopy. By uniting these technologies with increasingly accurate virtual reality technology, he said, long-distance examinations could become a real possibility.
In relation to the role of the RCVS, Adam explored how the profession could be proactive in engaging with these technologies, such as by: using regulation as a mechanism to attract 'disruptors' to work alongside the profession; identifying areas of retraining and creating targeted learning opportunities; fostering an entrepreneurial mindset; creating an early-adopter network of practices to foster initial collaboration; and framing industry challenges as targeted problems whose solutions can be crowd-sourced.
1,300 veterinary surgeons responded to the BVA survey, which was carried out in July. They were asked what Official Controls Qualification (OCQ) they hold or have held in the past, and give reasons for dropping a previously held qualification or choosing not to revalidate.
According to the BVA, many respondents criticised the current training and revalidation process, which is administered by Improve International on behalf of the Animal and Plant Health Agency (APHA).
Factors including time, the cumulative cost of renewing each module at regular intervals, a lack of relevance and duplication of learning across different modules were all cited as reasons for choosing to drop qualifications.
25% of vets who currently hold the Essential Skills OCQ say they are planning not to renew the qualification, with 67% saying it is because of the expiry of grandfather rights and 66% saying it is because they find the requirements too onerous.
18% of those who currently hold the Tuberculin Testing OCQ are not planning on renewing, either because they are finding the revalidation requirements too onerous (58%), too expensive (42%) or because the work is not sufficiently rewarding (42%).
35% of those who hold the Statutory Surveillance OCQ are not planning on renewing, primarily because of overly onerous revalidation requirements.
The largest drop off is predicted amongst holders of the Exports OCQ, 38.4% of whom said they plan not to revalidate.
Amongst the species bolt-ons, 45.5% of the holders of the Small Animal Exports OCQ, 51% of the Ungulate Exports OCQ, 66% of the Equine Exports OCQ, 72.5% of the Avian Exports OCQ, 47% of the Product Exports OCQ, 68% of the Germinal Products Exports OCQ and 32% of the Companion Animals OCQ said they plan not to renew, either because of the expiry of grandfather rights, or the expense or, in the case of Ungulate Exports, because revalidation is too onerous.
In the current system equine exports are included in the ungulate export OCQ, which the BVA says was a concern for those vets who only work with farm animals. APHA and Improve International have helpfully introduced an equine-only OCQ for exports that better meets the needs of equine-only vets.
BVA reports that it has had a positive meeting with APHA to discuss the survey results and explore practical solutions to iron out issues with the current system and make it easier to use. As a next step, BVA has agreed to review the modules and make recommendations for improving the structure of training and the revalidation process.
BVA President John Fishwick said: "The unprecedented response rate to this survey really hits home the strength of feeling on this issue. There is an urgent need to review and improve the revalidation process to safeguard against capacity and capability issues in this critical section of the workforce.
"It’s really positive that APHA recognises that there are issues with the current system and is keen to work with us to make it more proportionate and fit for purpose while continuing to maintain high standards. It’s more important than ever to retain skilled professionals so that the workforce is at full strength to respond robustly to disease outbreaks and meet demand for export certification after Brexit."
Andrew Soldan, APHA Veterinary Director said: "The integrity of our official controls and export certification is vitally important. The Official Controls Qualifications are a key part of this as they provide standardised OV training as well as assurance of high standards. I’m grateful to BVA for their assistance as we look to make further improvements to the system in the future."
Novartis Animal Health has announced the launch of a campaign to improve awareness of and improve education about atopic dermatitis (AD), to coincide with the 10th anniversary of Atopica.
As part of the campaign, the company is inviting veterinary surgeons to take part in an online survey for the chance to win an iPad mini: www.surveymonkey.com/s/atopica
In addition, Novartis says it will be offering all sorts of new educational materials for both vets and owners, including research into current trends and attitudes towards AD, insights from experts in the field, and case studies.
Ricardo Garvao, Category Manager for Atopica said: "This year marks an important milestone for the Atopica brand that wouldn't have been possible without the backing of so many vets. Continued investment by Novartis Animal Health into research and education seems a fitting way to extend thanks for this support and so forms one of the key elements of the 'Decade of Comfort' campaign. I am constantly amazed at just how dedicated and hard-working vets are and am immensely proud that Novartis Animal Health shares their goal to help pets remain happy and healthy."